Study to Assess Bronchospasm Potentially Induced by Next-Generation Propellant vs HFA Propellant in an MDI in Participants With Well/Partially Controlled Asthma

计划入组 52 人 · 首次发布于 2023 年 5 月 9 日

Multiple-dose Pharmacokinetics Study of "SYN006 HFA MDI" Administered Orally to Healthy Volunteers

计划入组 16 人 · 首次发布于 2014 年 6 月 17 日

Albuterol HFA MDI in Pediatric Participants With Asthma

计划入组 103 人 · 首次发布于 2007 年 12 月 20 日

SYN-006

Levosalbutamol(Xopenex)

C₁₃H₂₁NO₃ · Rx

Salbutamol(Airomir, Airsupra, Combivent, Proair, Proventil, Ventolin)

C₁₃H₂₁NO₃ · Rx

MDI Therapeutics, Inc.

United States

MI ZHOU & JIAN MEI WANG

Australia

MTI

AstraZeneca Completes Phase 3b Asthma Study Evaluating HFO MDI Safety and Launches China Observational Study

GSK's Next-Generation Low-Carbon Ventolin Inhaler Shows Therapeutic Equivalence in Phase III Trial

Aurobindo Pharma Wins FDA Approval for First Metered-Dose Inhaler, Generic Beclomethasone Aerosol